Europe
Motif Bio plc notes the announcement made today via RNS by Amphion Innovations plc that Amphion had reached an agreement in principle, subject to entering into a binding agreement, to extend the repayment of the loan facility by one year until 30 September 2019.
CASH POSITION AT JUNE 30, 2018: €14.9 million
A recently launched development project called Sami&Samu is looking to introduce innovative renewable materials, surface finishes and textiles to Hospital Nova, a new hospital due to open in Central Finland in 2020.
Zealand Pharma has initiated the Phase 3 trial with dasiglucagon for treatment of severe hypoglycemia in children
MR Solutions’ latest cryogen-free hybrid PET-MR multi-modality imaging system for molecular research was on display at the World Molecular Imaging Congress held in Seattle in September 2018.
Topas Therapeutics GmbH today announced that the Company will participate at the following conferences this fall
LGC has today announced a further strengthening of its nucleic acid chemistry (NAC) offering with the acquisition of Berry and Associates, premier supplier of specialty oligo reagents.
Clyde Biosciences announced today that its proprietary CellOPTIQ® High Content Assay (HCA) outperformed other assay types in the global CiPA myocyte study designed to develop more accurate and comprehensive in vitro cardiac safety evaluation of new drugs.
DNAe was named ‘Most Innovative Team or Innovator of the Year’ at the inaugural 2018 Medtech Insight Awards.
Netherlands Enterprise Agency grants through a financial loan (“Innovatiekrediet”) €2.7 million for the development of a diagnostic skin cancer test.
PRESS RELEASES